Latest News

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 283
JOS-logo.gif

Article ID: 720913

Artificial pancreas system better controls blood glucose levels than current technology

Joslin Diabetes Center

A multi-center randomized clinical trial evaluating a new artificial pancreas system — which automatically monitors and regulates blood glucose levels — has found that the new system was more effective than existing treatments at controlling blood glucose levels in people with type 1 diabetes.The study showed that the system improved participants’ blood glucose control throughout the day and overnight.

Released:
16-Oct-2019 8:05 PM EDT
Open in New Tab
Comment
JOS-logo.gif

Article ID: 720111

The diabetes pandemic and the promise of connected care

Joslin Diabetes Center

Digital diabetes management systems (“connected diabetes care”) have the potential to become part of a new diabetes care model, augmenting the traditional practice of diabetes care by providing continuous and on-demand assistance that aligns with the 24/7 demands of diabetes as a chronic disease.

Released:
3-Oct-2019 10:05 AM EDT
Open in New Tab
Comment

Research Results

Channels:

All Journal News, Diabetes,

Languages:

English

JOS-logo.gif

Article ID: 719914

High-fructose + high-fat diet damages mitochondria in the liver increasing risk of fatty-liver disease and metabolic syndrome

Joslin Diabetes Center

BOSTON – (October 1, 2019) – Researchers at Joslin Diabetes Center have found that high levels of fructose in the diet inhibit the liver’s ability to properly metabolize fat. This effect is specific to fructose. Indeed, equally high levels of glucose in the diet actually improve the fat-burning function of the liver. This explains why high dietary fructose has more negative health impacts than glucose does, even though they have the same caloric content.

Released:
1-Oct-2019 11:05 AM EDT
Open in New Tab
Comment
JOS-logo.gif

Article ID: 716537

Discovery enables clear identification of diseased beta cells in type 2 diabetes

Joslin Diabetes Center

BOSTON – (July 29, 2019) – Researchers at Joslin Diabetes Center, an affiliate of Harvard Medical School, have unlocked the key to clearly identifying diseased beta cells in type 2 diabetes. This discovery has both research and therapeutic implications.Studies of diabetes rely on the ability of researchers to sort diseased cells from healthy cells.

Released:
29-Jul-2019 11:05 AM EDT
Open in New Tab
Comment
Newswise: Ann Lagasse Elected to Chair of Board of Trustees

Article ID: 715577

Ann Lagasse Elected to Chair of Board of Trustees

Joslin Diabetes Center

Ann Lagasse, principal at Ocean's Havens, LLC, of Newburyport, MA, has been elected to be the next chair of the Joslin Diabetes Center Board of Trustees.

Released:
10-Jul-2019 3:05 PM EDT
Open in New Tab
Comment

Announcement

Channels:

Diabetes, Entrepreneurship,

Languages:

English

Newswise: Martin Pasqualini Elected to Joslin Diabetes Center Board of Trustees

Article ID: 715536

Martin Pasqualini Elected to Joslin Diabetes Center Board of Trustees

Joslin Diabetes Center

Martin Pasqualini, Managing Director of the CGA Group, has been elected to the Board of Trustees of Joslin Diabetes Center, an affiliate of Harvard Medical School.

Released:
10-Jul-2019 10:05 AM EDT
Open in New Tab
Comment

Announcement

Channels:

Diabetes, Entrepreneurship,

Languages:

English

Newswise: Susan Dacey Elected to Joslin Diabetes Center Board of Trustees

Article ID: 715534

Susan Dacey Elected to Joslin Diabetes Center Board of Trustees

Joslin Diabetes Center

Susan Dacey, CEO and Chair of the Board of Directors for Industrial Polymers and Chemicals, Inc. has been elected to the Joslin Board of Trustees.

Released:
10-Jul-2019 10:05 AM EDT
Open in New Tab
Comment

Announcement

Channels:

Diabetes, Entrepreneurship,

Languages:

English

Newswise: Todd Abbrecht Elected to Joslin Diabetes Center Board of Trustees

Article ID: 715533

Todd Abbrecht Elected to Joslin Diabetes Center Board of Trustees

Joslin Diabetes Center

Todd Abbrecht, Head of Private Equity at Thomas H. Lee Partners, has been elected to its Board of Trustees of the Joslin Diabetes Center, an affiliate of Harvard Medical School.

Released:
10-Jul-2019 10:05 AM EDT
Open in New Tab
Comment

Announcement

Channels:

Diabetes, Entrepreneurship,

Languages:

English

JOS-logo.gif

Article ID: 715349

Joslin Diabetes Center Remembers Lee Iacocca

Joslin Diabetes Center

Joslin Diabetes Center, an affiliate of Harvard Medical School, is paying tribute to the late Lee Iacocca, who passed away on July 2, at age 94. Mr. Iacocca was a generous supporter of research to find a cure for type 1 diabetes.

Released:
3-Jul-2019 4:25 PM EDT
Open in New Tab
Comment

Feature

Channels:

Recently Deceased,

Languages:

English

JOS-logo.gif

Article ID: 715348

Joslin Researchers Uncover Protective Factor in Diabetic Eye Disease

Joslin Diabetes Center

Researchers at Joslin Diabetes Center have shown that a protein found in the eye can protect against and potentially treat diabetic eye disease. At high enough levels, Retinol Binding Protein 3 (or RBP3) prevents the development of diabetic retinopathy. If introduced early enough in the development of the disease, RBP3 was shown to reverse the effects of the complication in rodent models of diabetes.

Released:
3-Jul-2019 4:15 PM EDT
Open in New Tab
Comment

Research Results

Channels:

Diabetes, Vision, All Journal News,

Languages:

English


Showing results

110 of 283

Chat now!